Infographics
-
Changes In Manufacturing Pipeline Focus
3/13/2020
This infographic reveals how many buyers of outsourced manufacturing services will increase their focus on biomanufacturing (including biosimilars), combined therapies, and focused therapies like ADCs.
-
3 Year Rolling Average – Biologic API Customer Loyalty
1/14/2020
ISR asked sponsors who outsource biologic API for insight into their customer loyalties. Here's how those outsourcers ranked. (From ISR's Biologic API Contract Manufacturer Quality Benchmarking, 4th Edition)
-
Top Five Oral Dosage Forms By Portfolio Composition
9/12/2019
The top five oral dosage forms account for more than half of products in oral dose portfolios and are: tablets, capsules, controlled release tablets, controlled release capsules, and immediate release tablets.
-
How Experience, Capacity Shape Sterile Injectables Outsourcing
7/16/2019
ISR asked 43 outsourcers of sterile injectable drug products why manufacturing might be split between in-house and external resources. More than half said their companies lack capacity.
-
How Do Experience And Capacity Impact Small Molecule API Outsourcing?
7/16/2019
ISR asked 60 outsourcers of small molecule drug substance manufacturing to select from four different reasons that manufacturing may be split between in-house and external resources.
-
Top Five Satisfaction Drivers For Outsourced Oral Dose Manufacturing
6/14/2019
In Q1, 2019, ISR surveyed 102 sponsors who outsource oral dosage form manufacturing to improve our understanding of what influences customers satisfaction.
-
Top Five Satisfaction Drivers For Outsourced Bioprocessing
6/14/2019
ISR surveyed 100 sponsors who outsource bioprocessing to learn what drives CMO satisfaction. Learn why Quality compliance and Technical capabilities and technical service lead satisfaction drivers.
-
Customer Loyalty In Biologic Drug Product Manufacturing
5/15/2019
ISR surveyed sponsors who outsource drug substance manufacturing for biologic compounds to gain insight into their CMO loyalty. ISR computes customer loyalty as an index that consists of overall satisfaction, willingness to recommend, and likelihood to use the CMO again.
-
Biologic Drug Substance And Drug Product Preferred Provider Use
4/15/2019
ISR data shows the majority of those who outsource biologic drug substance and drug product use a preferred provider approach to outsourcing, and average about four CMOs on their lists.
-
How Do Experience And Capacity Impact Oral Dose Outsourcing?
2/25/2019
In Q2 2018, ISR asked 44 outsourcers of oral solid dose drug product manufacturing to select from four different reasons that manufacturing may be split between in-house and external resources.